Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

U.S. FAA approves use of Moderna COVID-19 vaccine by pilots

Published 12/19/2020, 03:15 PM
Updated 12/19/2020, 03:20 PM
© Reuters. FILE PHOTO: A pilot walks past a closed restaurant at IAH George Bush Intercontinental Airport in Houston
PFE
-
DAL
-
AAL
-
MRNA
-

By David Shepardson

WASHINGTON (Reuters) - The U.S. Federal Aviation Administration (FAA) said on Saturday it had approved the use of the Moderna (NASDAQ:MRNA) COVID-19 vaccine by pilots and air traffic controllers.

The announcement follows the FAA's Dec. 12 approval for pilots and controllers to use the vaccine from Pfizer (NYSE:PFE) and BioNTech

The U.S. aviation regulator said pilots and controllers must not fly or conduct safety-related duties for 48 hours after receiving doses. The FAA said it "will monitor the patient response to each vaccine dose and may adjust this policy as necessary to ensure aviation safety."

On Thursday, groups representing aviation unions and American Airlines (NASDAQ:AAL), United Airlines, Delta Air Lines (NYSE:DAL) and other airlines, wrote all U.S. governors asking them to "prioritize aviation frontline workers for allocation of the vaccine in your upcoming implementation plan."

The groups noted that "aviation workers are frontline workers who either encounter the traveling public frequently or are required to perform our work in close proximity to our colleagues and perform our jobs onsite."

Earlier this month, the FAA sent guidance to airports to prepare for vaccine distribution, including other facilities that may serve as alternate or diversion airports.

© Reuters. FILE PHOTO: A pilot walks past a closed restaurant at IAH George Bush Intercontinental Airport in Houston

The FAA said that some aircraft used for vaccine shipments may be larger than the aircraft used for passenger-carrying flights that typically serve that airport and operators may opt to have extra aircraft rescue and firefighting services.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.